BillionToOne Backs Annual Outlook; Initiates 2026 Revenue Guidance Above View
(RTTNews) - BillionToOne, Inc.(BLLN), a molecular diagnostics company, on Monday reaffirmed its outlook for fiscal 2025 and initiated guidance for 2026...
Nasdaq News: Markets·27d ago